|
|
Article: New Jersey Jury Awards $12.9 Million to Three Patients Whose Use of Roche Acne Medication Accutane Found to Cause Severe Bowel Illness.
- Article from:
- PR Newswire
- Article date:
- November 20, 2008
CopyrightCOPYRIGHT 2008 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Three Florida residents took Accutane as teens, developed inflammatory bowel disease; Plaintiffs represented jointly by law firms Hook Bolton; Seeger Weiss; and Beggs & Lane
ATLANTIC CITY, N.J., Nov. 20 /PRNewswire/ -- In another major courtroom verdict linking powerful acne medication Accutane with long-term inflammatory bowel disease (IBD), an eight-person jury in Atlantic City has found that pharmaceutical maker Hoffman-La Roche (OTCQX: RHHBY; VTX: ROG.VX) failed to provide adequate warning of the possible condition to three patients who began taking the drug as teenagers and shortly thereafter developed severe forms of IBD. The jury awarded compensatory ...